Table II.
Category | Basal | End of 3-month treatment | P-valuea |
---|---|---|---|
General health | 30.0 (21.0–36.0) | 32.0 (25.0–40.0) | 0.178 |
Physical function | 82.5 (51.2–95.0) | 80.0 (55.0–95.0) | 0.938 |
Physical health problems | 35.0 (0.0–40.0) | 40.0 (40.0–40.0) | 0.017b |
Emotional problems | 30.0 (2.5–30.0) | 30.0 (30.0–30.0) | 0.026b |
Emotional function | 29.0 (24.5–30.0) | 30.0 (27.0–30.8) | 0.433 |
Energy fatigue | 20.0 (18.0–20.0) | 19.2 (17.1–21.5) | 0.948 |
Social function | 13.5 (9.1–18.0) | 17.5 (15.6–20.0) | 0.008b |
Pain | 18.0 (13.5–20.0) | 17.0 (13.5–20.0) | 0.797 |
Values are presented as the median and interquartile range.
Wilcoxon signed-rank test
significant to P<0.05 (two-tailed).